Market Trends of Japan Mammography Industry
3D mammography segment is Expected to Hold a Significant Market Share Over the Forecast Period
3D mammography, also known as digital breast tomosynthesis (DBT)/is a new technology that helps improve the radiologist's ability to diagnose breast cancer. These types of mammography use a series of two-dimensional images to build a three-dimensional image of the breast.
The segment is expected to grow during the forecast period with the high efficacy of breast tomosynthesis and advancing research. For instance, a study published in the journal Breast Cancer in March 2021 stated that the recall rate was improved by using digital breast tomosynthesis (DBT) for breast cancer screening in Japanese women. The study observed that cancer detection rates were the same in DBT and digital mammography alone. The study further emphasized that breast cancer screening combined with DBT is helpful for Japanese women to reduce unnecessary further examination. Also, in Japan, there is an urgent need to develop alternate screening methods to enhance the imaging capabilities of mammography systems to screen women aged 40 to 49 years. This is expected to increase the adoption of more 3D mammography systems with high resolution and imaging capabilities; thus, such research studies improve the awareness and growth of the segment.
Further, a study published in the BMC Medical Imaging in January 2023 stated that 3D mammography and a guided vacuum-assisted biopsy offered mammography imaging enabled clinicians to make quick decisions about the target coordinates and enhance the clinical performance of microcalcification biopsies. Such studies underline mammography's efficacy and technological enhancements that are likely to elevate the adoption of 3D mammography by the end users. These factors are expected to increase the segment's growth in the coming years.
Therefore, the 3D mammography segment is expected to witness significant growth over the forecast period due to the abovementioned factors, including the high efficacy of 3D mammography and advancing research.
The Specialty & Diagnostic Centre segment is Expected to Hold a Significant Market Share Over the Forecast Period
The specialty & diagnostic center is a sophisticated and well-equipped healthcare facility that offers end-to-end diagnosis and treatment specifically for cancer. The segment is anticipated to grow with the introduction of advanced infrastructure for the diagnosis of a variety of cancer, including breast cancer, and the other developments by the specialty & diagnostic center, which will increase its penetration to a more patient base of breast cancer. For instance, as per the data published by the Union for International Cancer Control in May 2023, the national cancer center, which is one of the specialty cancer centers in Japan, plays a crucial role in cancer screening in Japan. The source stated that the center carries out research on prevention and screening, as well as translational and clinical research, and hosts the national cancer registry and a national database for cancer genomic medicine. Such diverse roles of cancer screening and diagnosis will attract more patients of breast cancer to the specialty & diagnostic center and boost the segment's growth with a higher volume of mammography.
Several specialty & diagnostic centers in Japan have taken strategic decisions, such as collaborations, partnerships, and others, which will increase the penetration of the specialty & diagnostic center in the market to access more breast cancer patients and offer mammography diagnosis. For instance, in May 2022, the National Cancer Center (NCC) of Japan signed a partnership with FathomX Pte Ltd, artificial intelligence (AI) based mammography diagnostics company, for the research and development of a medical device for women for breast cancer diagnosis using the data from the mammogram and AI. With such research collaborations, the diagnosis of breast cancer patients at the specialty & diagnostic center will improve, which will boost the volume of diagnoses of breast cancer imaging at the specialty & diagnostic centers in the country and bolster the segment's growth in the coming years.
Therefore, with the advanced infrastructure and the recent developments, the studied segment is anticipated to grow during the forecast period.
